Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
Sep 15, 2025, 8:00 PM EDT
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of $67.75 million as of September 17, 2025. Its market cap has increased by 0.42% in one year.
Market Cap
67.75M
Enterprise Value
58.92M
Revenue
3.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 11.50M to 67.75M, an increase of 489.21%. That is a compound annual growth rate of 10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 67.79M | 39.86% |
| Dec 31, 2024 | 48.47M | 40.08% |
| Dec 29, 2023 | 34.60M | -71.81% |
| Dec 30, 2022 | 122.77M | -40.54% |
| Dec 31, 2021 | 206.48M | 778.52% |
| Dec 31, 2020 | 23.50M | -16.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |